Non-invasive synergistic treatment of brain tumors by targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxide.
Authors: Yang HW, Hua MY, Hwang TL, Lin KJ, Huang CY, Tsai RY, Ma CC, Hsu PH, Wey SP, Hsu PW, Chen PY, Huang YC, Lu YJ, Yen TC, Feng LY, Lin CW, Liu HL, Wei KC
The combination of chemo-thermal therapy is the best strategy to ablate tumors, but how to heat deep tumor tissues effectively without side-damage is a challenge. Here, a systemically delivered nanocarrier is designed with multiple advantages, including superior heat absorption, highly efficient hyperthermia, high drug capacity, specific targeting ability, and molecular imaging, to achieve both high antitumor efficacy and effective amplification of hyperthermia with minimal side effects.
Introduction
Purpose
Drug delivery WITHOUT BBB opening
Study Objective
To develop and evaluate a non-invasive synergistic treatment for brain tumors combining targeted chemotherapeutic delivery and amplified focused ultrasound-hyperthermia using magnetic nanographene oxide.
Disease model
brain tumors
Cargo name and characteristics
Chemotherapeutic small molecule delivered via magnetic nanographene oxide nanoparticles (targeted chemotherapeutic delivery)
Outcomes and Safety
Summary of Outcomes
The study reports a non-invasive, synergistic approach combining targeted chemotherapeutic delivery with amplified focused ultrasound (FUS)‑induced hyperthermia using magnetic nanographene oxide, resulting in enhanced localized tumor suppression and cell kill in brain tumors. The title does not report specific focused ultrasound parameters or which parameter sets were successful.
Safety-related matter
No safety issues or adverse effects are mentioned in the provided text.
Brain Region
Ultrasound Parameters
Focal Characteristics
Focal depth: None; Focal length: None; Aperture size: None
We are open to feedback. If you see a mistake or have a suggestion, please contact us.
← Back to Search